Literature DB >> 10618015

Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.

L W Roberts1, T D Warner, J L Brody.   

Abstract

OBJECTIVE: Significant controversy surrounds the ethics of psychiatric research. Nevertheless, few data have been gathered to improve our understanding of how individuals with serious mental illness and psychiatrists view ethically important aspects of biomedical research participation.
METHOD: The authors assessed views of clinically diagnosed patients with schizophrenia from three sites by means of structured interviews and views of psychiatrists at two sites with written surveys regarding attitudes affecting motivation to participate in biomedical research, attitudes related to autonomy and influences on participation decisions, and attitudes toward the inclusion of vulnerable populations in research. The schizophrenia patients were asked to indicate their personal views; the psychiatrists were asked to provide their personal views and to predict schizophrenia patients' views. Responses were compared by using repeated measures multivariate analysis of variance.
RESULTS: Sixty-three patients with schizophrenia and 73 psychiatry faculty and residents participated. Overall, responses to 23 rated attitudes revealed remarkably similar rank orders and several areas of agreement between patients and psychiatrists. Both groups strongly supported schizophrenia research and autonomous decision making by participants. They saw helping others and helping science as important reasons for protocol participation. Patients endorsed the feeling of hope associated with research involvement, a perspective underestimated by psychiatrists. Psychiatrists also underestimated the patients' acceptance of physician, investigator, and family influences on participation decisions. Psychiatrists agreed more strongly than patients that vulnerable populations should be included in research.
CONCLUSIONS: This study helps to characterize previously neglected attitudes of psychiatric patients and clinicians toward ethically important aspects of biomedical research participation. Schizophrenia patients offered highly discerning views, and interesting similarities and differences emerged in comparing responses of patients and psychiatrists.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Mental Health Therapies

Mesh:

Year:  2000        PMID: 10618015     DOI: 10.1176/ajp.157.1.67

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  33 in total

Review 1.  Benefits and burdens of placebos in psychiatric research.

Authors:  Scott Y H Kim
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

Review 2.  Turn-of-the-century ethical issues in child psychiatric research.

Authors:  L E Arnold
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  Screening for understanding of research in the inpatient psychiatry setting.

Authors:  Norval J Hickman; Judith J Prochaska; Laura B Dunn
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

Review 4.  Early intervention in schizophrenia: three frameworks for guiding ethical inquiry.

Authors:  Philip J Candilis
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

Review 5.  Ethical considerations in psychopharmacological research involving decisionally impaired subjects.

Authors:  Donald L Rosenstein; Franklin G Miller
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

Review 6.  Ethical issues in the use of animals in biomedical and psychopharmocological research.

Authors:  John P Gluck; Jordan Bell
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

Review 7.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

8.  A time of promise, a time of promises: ethical issues in advancing psychopharmacological research.

Authors:  Laura Weiss Roberts; John Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-11-13       Impact factor: 4.530

Review 9.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

10.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.